News and Analysis

Nature Reviews Drug Discovery 4, 704-705 (September 2005) | doi:10.1038/nrd1839

Acquisitions not a cure for antiinfectives

David Bradley

Top

Despite recent purchases, big pharma is still reluctant to return to the field.

Extra navigation

Open Innovation Challenges

naturejobs

natureproducts


Advertisement